Central to the probe are DEA's Thomas Prevoznik, DEA's Matthew Strait and DEA attorney Aarathi Haig within the DEA's Diversion Control Division, whose conduct has raised serious questions about the integrity of the DEA's regulatory processes.
Read More
With the launch of SupplierQuest, ComplianceQuest now delivers the industry's most complete platform for managing quality, compliance, safety, product, and supplier operations-all within one unified Middle Office solution.
Read More
As economic uncertainty grows and finances remain top of mind for consumers, MoneyBot5000’s new Plaid-powered Spending Tracker can help users take back control with real-time, automated insights into their spending.
Read More
During April, the top-rated multi-state podiatry practices emphasizes daily hygiene, exercise, preventive care and early intervention to resolve minor foot issues before they can become major health problems.
Read MoreRenowned AI technologist with dual Ph.D.s in Cloud Computing and Machine Learning joins Nixxy board
Founder of Scanbo and expert in real-time, non-invasive diagnostics powered by biosensor AI
30+ years leading secure, compliant platforms across healthcare, telecom, and fintech
Proven experience in SOC 2, GDPR, HIPAA, and end-to-end AI security frameworks
"This isn't just about paperwork - it's about a pattern of disregard for the law," said Duane Boise CEO MMJ International Holdings. "The DEA can't demand compliance from others while ignoring its own obligations."
Aarathi D. Haig, a DEA attorney central to the agency's controversial handling of MMJ Biopharma Cultivation's Bulk Manufacturers cannabis research application, is not in good standing with the New Jersey Bar. A February 2023 letter from the New Jersey Board of Bar Examiners states Haig is ineligible for a Certificate of Good Standing
Read More
The new website features improved functionality, simpler navigation and a greatly-enhanced user experience. Visitors can enjoy ITPro's trademark mix of exclusive product reviews, expert analysis and industry news now more easily than ever.
Read MoreSea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system)
Sea's lead molecule SPM-0404 is a potential new oral treatment in investigational new drug (IND)-enabling studies for constant bothersome tinnitus, epilepsy, and sporadic ALS (S-ALS)
Pre-clinical development work by Inotiv, Inc. to support Sea filing IND application at FDA
Inotiv Inc will assist Sea to quantify SPM-0404 levels in Clinical Phase 1 and Ph.1b Trials
Exclusive documents obtained reveal DEA Attorney Aarathi Haig, the key DEA attorney in MMJ's cannabis research constitutional Administrative Law Judge case, is ineligible for a Certificate of Good Standing in the N.J. Bar due to compliance failures.
Read More